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The paper by Body et al is concerned with the evaluation of decision aids which can be used to identify 
potential acute coronary syndromes (ACS) in the ED. The authors previously developed the Manchester 
Acute Coronary Syndromes model (MACS) decision aid which uses several clinical variables and two 
biomarkers to ‘rule in’ and ‘rule out’ ACS. However, one of the two biomarkers (H?FABP) is not widely 
used so a revised decision aid has been developed (Troponin?only Manchester Acute Coronary Syndromes, 
T?MACS) which include a single biomarker hs?cTnT. In this issue, the authors show how they derive a 
revised decision aid and describe its performance in a number of independent diagnostic cohort studies. 
Decision aids (as well as other types of “diagnostic tests”) are often evaluated in terms of diagnostic testing 
parameters such as the area under the ROC curve, sensitivity and specificity. In this article, we explain how 
the ROC analysis is conducted and why it is an essential step towards developing a test with the desirable 
levels of sensitivity and specificity.     
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Making a diagnosis is an important role for clinicians, and often a range of tests are used to supplement 
history?taking and examination. However, not all diagnostic tests are equal, hence it is important to evaluate 
the diagnostic abilities of those tests.  
 
What physicians want to know is whether a whether a specific condition is present, or not present. 
Diagnostic tests can produce either yes / no answers (binary results) or a number on a continuous scale. In 
the diagnosis of deep vein thrombosis (DVT), for example, Doppler ultrasound would produce a binary 
result (DVT present or absent). However, the serum D?dimer level used to detect DVT gives a number in a 
range of possible values. Diagnostic tests that produce continuous results are often dichotomised because the 
outcome of interest is generally binary. An example would be the threshold (or cut?off point) of 500 
micrograms/L to distinguish between a ‘positive’ and a ‘negative’ D?dimer result.[1]   
 
One of the challenges in interpreting the results of diagnostic tests that produce continuous measures is the 
selection of the threshold to distinguish a ‘positive’ test from a ‘negative’ test. We used the paper by Body et 
al[2] as an example to illustrate the role of receiver operating characteristic (ROC) curve in choosing the 
threshold cut?offs for the newly derived T?MACS score. The original MACs score used two thresholds to aid 
clinical decision making. A low threshold was set to ‘rule?out’ a diagnosis of ACS and a higher threshold 
was used to ‘rule?in’ a diagnosis of ACS. Patients with test results falling between these two thresholds 
would require further clinical observation. The T?MACS (and the original MACS) score estimate the 
probability of ACS from 0 (lowest probability) to 1 (highest probability).  
 
 
 
#$$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#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To produce a ROC curve, the sensitivities and specificities for different values of a continuous test measure 
are first tabulated.  This results, essentially, in a list of a various test values and the corresponding sensitivity 
and specificity of the test at that value.  Then, the graphical ROC curve is produced by plotting sensitivity 
(true positive rate) on the y?axis against 1– specificity (false positive rate) on the x?axis for the various 
values tabulated.   
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A ROC curve that follows the diagonal line y = x produces false positive results at the same rate as true 
positive results. Therefore we expect a diagnostic test with reasonable accuracy to have a ROC curve in the 
upper left triangle above the y = x line (‘reference line’) of Figure 1.  
 
The area under the ROC curve (AUC) is a global measure of a test’s ability to discriminate whether a 
specific condition is present or not present. An AUC of 0.5 represents a test with no discriminating ability 
(i.e. no better than chance) while an AUC of 1.0 represents a test with perfect discrimination. The 
(unpublished) ROC curve for ACS (Figure 1) which was generated from the T?MACS scores calculated for 
the derivation set has an AUC of 0.94 after correction for in?sample optimism by cross?validation, which 
would suggest that T?MACS score is a very good discriminator of ACS vs no ACS.  
 
When selecting an optimal threshold (or cut?off point) we need to consider the aims of the diagnostic test, 
considering the significance and costs of a false positive or false negative interpretation. A commonly used 
approach when selecting a cut?off point is to give equal weight to the importance of sensitivity and 
specificity by choosing the point nearest to the top?left most corner of the ROC curve.[3] This point is also 
known as the Youden Index.[4] We illustrate how this is done using Figure 1. If the interest was to simply 
find the optimal trade?off between sensitivity and specificity then a T?MACS score of  ≥ 0.34 represents this 
point of balance. We can read from the ROC curve that sensitivity is 83.4% and specificity is 94.6% at this 
threshold. If we use this threshold, then the T?MACS score has an accuracy of 92.2% in detecting ACS 
among adults presenting to ED with chest pain in the study. Accuracy is defined as the proportion of correct 
decisions (i.e. true positive + true negative) over the number of total tested.[5] The AUC can be thought of 
an indicator of overall “accuracy”, and there is only one AUC value for each ROC curve. On the other hand, 
‘accuracy’ will vary from point?to?point along the ROC curve, as there is variation in sensitivity and 
specificity from point?to?point (see Table 1). 
 
Table 1: The sensitivity and specificity of the various T?MACS thresholds for ACS (derivation set) 



)
)
(95% CI) 

(95% CI) 
	
(95% CI) 

' * (i.e. very low risk = 
negative test) 
 


+,-./ (95.3% – 99.8%) 


0.-1/ (43.4% – 51.9%) 
 
2,-1 (55.0 – 62.3) 
3* (i.e. very low risk & 
low risk = negative test) 

+0-4/ (89.0% – 97.2%) 

1,-2/ (64.4% – 72.3%) 
 
.0-4 (70.7 – 77.2) 

&
 * (i.e. very low risk, low 
risk & moderate risk = negative test) 



0.-4/ (38.9% – 55.3%) 


544-4/ (99.3% – 100.0%)

,,-1 (86.3 – 91.0) 
 
Sensitivity is the proportion of true positives that are correctly identified by the test 
Specificity is the proportion of true negatives that are correctly identified by the test 
Accuracy is the proportion of correct decisions (i.e. true positive + true negative) over the number of total 
tested 
 
By selecting the threshold based on the trade?off between sensitivity and specificity, we are assuming that 
the balance between false positive and false negative rates is not clinically important.[6] This may not be true 
in two common scenarios. The first scenario is when the clinical risk of missing a particular diagnosis is 
disproportionate to the risk of over?diagnosis (or vice versa). The second scenario is when the primary 
intended use of a diagnostic test is for either “ruling?in” or “ruling?out” a target condition. In these scenarios, 
it is important to understand the balance between the two types of errors and to select the threshold 
accordingly.  
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Body et al selected a threshold of 0.02 for T?MACS and classify patients below this value as ‘ruled?out’ (i.e. 
very low risk) using the derivation set. This threshold has very high sensitivity (98.7%) – so if a patient score 
is this low, we are very confident they are at very low risk of ACS. However, scores above this threshold are 
only 47.6% specific, hence the accuracy of detecting ACS with this threshold is only 58.6%. As noted above, 
a T?MACS score threshold of 0.34 represents the optimal balance between sensitivity and specificity, thus 
has a higher accuracy of 92.2%. However, this threshold only has a sensitivity of 83.4% for detecting ACS. 
This means around 16.6% of adults presenting to ED with chest pain that have ACS will be undetected if a 
T?MACS score of < 0.34 is considered a ‘negative’ test result. Therefore, despite the lower accuracy of with 
a threshold of 0.02, it is a more useful threshold for ‘ruling out’ ACS since less than 2% of ACS cases will 
be undetected.  
 
Body et al also selected a higher threshold of 0.95 for ‘ruling in’ ACS. This threshold also has a modest 
accuracy of 88.6%, due to the low sensitivity of 47.0%. However, this threshold has a specificity of 100%, 
which means there is no false positive result. We can therefore be confident that a patient at this higher 
threshold is at a very high risk for ACS. In contrast, a T?MACS score of ≥ 0.34 will result in a false positive 
rate of 5.4% despite its superior accuracy of 92.2%.  
 
Table 1 represents the sensitivity and specificity of the various T?MACS thresholds for ACS using the 
derivation set, linking to the results tabulated in Table 4 of the paper by Body et al. Table 1 illustrates the 
rising specificity and declining sensitivity with higher threshold values. 
 
A strength of the study by Body et al is the re?evaluation of the selected thresholds using a validation set. 
This yielded very similar results to the derivation set (e.g. the sensitivity for the ‘ruled out’ threshold for 
ACS remains very high at 98.1%), suggesting that the thresholds selected are indeed robust. 
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The ROC curve can be used to determine an appropriate cut?off, affecting the sensitivity and specificity of 
the test. The selection of a test threshold depends on the purpose of the test and not necessarily just by giving 
equal weight to sensitivity and specificity to achieve higher accuracy. 
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